The Endocrinology and Metabolism Market is witnessing rapid expansion due to the rising prevalence of diabetes and obesity in both developed and emerging regions.

Clinics offering integrated treatment plans, including lifestyle interventions, medication, and monitoring devices, are driving adoption. Increased awareness and preventive care initiatives further support long-term market growth across the Asia-Pacific, North America, and Europe regions.

Market Outlook: Valued at USD 28.5 billion in 2024, the market is projected to reach USD 46.7 billion by 2034, at a 5.8% CAGR.